Anzeige
Mehr »
Montag, 25.08.2025 - Börsentäglich über 12.000 News
Mega-Deal in Kanada: Katapultiert sich diese Aktie jetzt in die Top-Liga der Explorer?
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche
ACCESS Newswire
378 Leser
Artikel bewerten:
(1)

Vitana-X Plans to Open in Russia by the End of 2021

MIAMI, FL / ACCESSWIRE / September 22, 2021 / VitanaX, Inc. (OTC:VITX), a provider of comprehensive programs for greater well-being, fitness and health with a wellness network marketing program, is pleased to announce it plans to start to sell in Russia before the end 2021.

Founder Bernhard Sammer expects the necessary product certifications to be granted shortly. Currently they are being processed by the 'Household Institution for Healthcare FBUZ at the Center for Hygiene and Epidemiology in St. Peterburg' and should be issued immediately.

At the time of the opening, Vitana-X will have CBD-, CBN-, CDE-, OMEGA-Droplets available for the distributors and resale to customers.

Founder Bernhard Sammer, commented, "To establish our presence in Russia, we are considering a licensee model such as a master distributorship ongoing with the founding of a corporation on location. At the beginning we will start our activities in the metro areas of St. Peterburg and Moscow. Later we will expand step by step into overall Russia."

The ranking of the World Federation of Direct Selling Associations (WFDSA) ranks Russia as #4 in Europe and #15 globally. In 2020, 4.6 million distributors generated annual sales of $2.2 billion.

Sammer, continued, "Over time we've been observing a constant growth of the potential group of buyers for our innovative products and have been preparing our market entry. Overall Russia has a high need for risk -free business opportunities. This is indicated be the high number of fulltime and parttime people already involved in Direct Selling."

In addition to its own potential Russia as the nucleus of the former USSR is also able to take over the role of a hub looking at a possible expansion into the numerous bordering ex-Soviet Republics, which are now independent countries today, such as Azerbaijan or Kazakhstan.

About Vitana-X

Vitana-X, Inc.'s (OTC:VITX) Vitana-X, an international wellness company specializing in the development and manufacture of health-promoting products based on DNA analysis. As a pioneer in this industry and a worldwide network of highly qualified experts, it offers its customers extensive opportunities to lead a healthier life. Vitana-X offers comprehensive programs for greater well-being, fitness and health by helping you achieve the desired results and offering exercises that fit your body type. Vitana-X wants to support people in their healthy development and be their reliable partner for their full potential. Vitana-X comes from two worlds and wants to unite them in the future - science and the challenges of daily life, so that its customers can continue to care for other areas of life without sacrificing a healthy life.

For additional information on Vitana-X, please visit: https://vitanax.net/en/

Forward-Looking Statements

Forward-Looking Statements. This press release contains "forward-looking statements" within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended (the "Exchange Act") (which Sections were adopted as part of the Private Securities Litigation Reform Act of 1995). Statements preceded by, followed by or that otherwise include the words "believe," "anticipate," "estimate," "expect," "intend," "plan," "project," "prospects," "outlook," and similar words or expressions, or future or conditional verbs such as "will," "should," "would," "may," and "could" are generally forward-looking in nature and not historical facts. These forward-looking statements involve known and unknown risks, uncertainties and other factors which may cause the Company's actual results, performance or achievements to be materially different from any anticipated results, performance or achievements. The Company disclaims any intention to, and undertakes no obligation to, revise any forward-looking statements, whether as a result of new information, a future event, or otherwise.

Contact Information

press.IRclear2157@gmail.com
www.vitanax.net
305-714-9397
bs@vitanax.com
Phone: +41 76 439 63 64 (Anna Gräfinger)

SOURCE: VitanaX, Inc.



View source version on accesswire.com:
https://www.accesswire.com/665154/Vitana-X-Plans-to-Open-in-Russia-by-the-End-of-2021

© 2021 ACCESS Newswire
Tech-Aktien mit Crash-Tendenzen
Künstliche Intelligenz, Magnificent Seven, Tech-Euphorie – seit Monaten scheint an der Börse nur eine Richtung zu existieren: nach oben. Doch hinter den Rekordkursen lauert eine gefährliche Wahrheit. Die Bewertungen vieler Tech-Schwergewichte haben historische Extremniveaus erreicht. Shiller-KGV bei 39, Buffett-Indikator auf Allzeithoch – schon in der Dotcom-Ära war der Markt kaum teurer.

Hinzu kommen euphorische Anlegerstimmung, IPO-Hypes ohne Substanz, kreditfinanzierte Wertpapierkäufe in Rekordhöhe und charttechnische Warnsignale, die Erinnerungen an 2000 und 2021 wecken. Gleichzeitig drücken geopolitische Risiken, Trumps aggressive Zollpolitik und saisonale Börsenschwäche auf die Perspektiven.

Die Gefahr: Aus der schleichenden Korrektur könnte ein rasanter Crash werden – und der könnte vor allem überbewertete KI- und Chipwerte hart treffen.

In unserem kostenlosen Spezial-Report zeigen wir Ihnen, welche Tech-Aktien am stärksten gefährdet sind und wie Sie Ihr Depot vor dem Platzen der Blase schützen könnten.

Holen Sie sich den neuesten Report!

Dieses exklusive Angebot gilt aber nur für kurze Zeit! Daher jetzt downloaden!
Werbehinweise: Die Billigung des Basisprospekts durch die BaFin ist nicht als ihre Befürwortung der angebotenen Wertpapiere zu verstehen. Wir empfehlen Interessenten und potenziellen Anlegern den Basisprospekt und die Endgültigen Bedingungen zu lesen, bevor sie eine Anlageentscheidung treffen, um sich möglichst umfassend zu informieren, insbesondere über die potenziellen Risiken und Chancen des Wertpapiers. Sie sind im Begriff, ein Produkt zu erwerben, das nicht einfach ist und schwer zu verstehen sein kann.